Studies how allergies affect biologic treatment response in severe asthma
Observes adults with severe asthma on biologic treatment, checking whether respiratory allergy matters.
Plain-language title generated from the registry record
Registry title: Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy
Key facts
- Where
- Poitiers, FranceSee the site
Where in France
- CHU PoitiersPoitiers, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Poitiers University Hospital
- Trial code
- NCT06916104
- Record updated
- 8 April 2025
- Original description
The aim of this study is to take stock of the situation of adult patients with severe asthma on biotherapy, followed up at Poitiers University Hospital, and in particular to increase our knowledge of factors predictive of response to biotherapy. The main aim is to improve the management of adult severe asthma patients treated with biotherapy, according to their allergic status.Read full original descriptionShow less
Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy
The aim of this study is to take stock of the situation of adult patients with severe asthma on biotherapy, followed up at Poitiers University Hospital, and in particular to increase our knowledge of factors predictive of response to biotherapy. The main aim is to improve the management of adult severe asthma patients treated with biotherapy, according to their allergic status.
Inclusion: Severe asthma patient on biotherapy; Age > or = 18 years; Follow-up at Poitiers University Hospital.
Exclusion: Absence of allergological assessment; Patient's refusal to participate in study.